TITLE

Post-transcriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and cholesterol 7α-hydroxylase in rats with subtotal nephrectomy

AUTHOR(S)
Pandak, William M.; Vlahcevic, Z. Reno; Heuman, D. M.; Krieg, Richard J.; Hanna, James D.; Chan, James C. M.
PUB. DATE
August 1994
SOURCE
Kidney International;Aug1994, Vol. 46 Issue 2, p358
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Chronic renal failure is associated with hyperlipidemia and atherosclerosis. The mechanism responsible for the observed increase of serum cholesterol in chronic renal disease is not certain. The objective of the present study was to characterize the effect of induced renal failure on 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-CoA reductase) and cholesterol 7α-hydroxylase, the two rate determining enzymes of the cholesterol and bile acid biosynthetic pathways, respectively. Studies were carried out in rats with subtotal (75%) nephrectomy, which resulted in a marked elevation of blood urea nitrogen (371 ± 44% of control, P < 0.001), and was accompanied by significant increases in the levels of serum cholesterol (1.33 ± 7%, P < 0.005) and triglycerides (185 ± 25, P < 0.01). In nephrectomized rats, an increase in the specific activity of HMG-CoA reductase (219 ± 30% of above control levels, P < 0.02) was observed. This increase occurred in the presence of elevated hepatic microsomal cholesterol concentrations (150 ± 13% of controls, P < 0.01). Surprisingly, the increase in HMG-CoA reductase specific activity was not associated with parallel increases in HMG-CoA reductase steady-state mRNA levels and gene transcriptional activity. These uremic rats also exhibited a marked increase in the specific activity of cholesterol 7α-hydroxylase (240 ± 559% of controls, P < 0.05). There was no concomitant increase in cholesterol 7α-hydroxylase steady-state mRNA levels or gene transcriptional activity. The factors responsible for the observed increases in HMG-CoA reductase and cholesterol 7α-hydroxylase specific activity in renal failure remain to he determined. In summary, renal failure induced by subtotal nephrectomy results in a twofold increase in HMG-CoA reductase activity (cholesterol synthesis), an increase which is coupled with a twofold increase in cholesterol 7α-hydroxylase activity (bile acid synthesis). The contribution of altered hepatic cholesterol metabolism to the elevated serum cholesterol levels observed in renal failure, and the net effect of increase of activity of these two enzymes on hepatic cholesterol homeostasis have not been ascertained in this study.
ACCESSION #
14889013

 

Related Articles

  • Should hyperlipemia of renal failure be treated? Ritz, Eberhard; Augustin, Jan; Bommer, Jurgen; Gnassa, Agostino; Haberbosch, Werner // Kidney International Supplement;Dec1985, Issue 17, pS84 

    Discusses the role of hyperlipemia in accelerated atherogenesis of uremia. Evidence showing beneficial effect of dietary lipid lowering on cardiovascular events; Questions whether the plasma lipid abnormalities should be normalized in uremic patients by dietary intervention; Potential roles of...

  • Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice. Vaziri, Nosratola D.; Kim, HyunJu; Moradi, Hamid; Farmand, Farbod; Navab, Kaveh; Navab, Mohamad; Hama, Susan; Fogelman, Alan M.; Quiroz, Yasmir; Rodriguez-Iturbe, Bernardo // Nephrology Dialysis Transplantation;Nov2010, Vol. 25 Issue 11, p3525 

    Background. There is mounting evidence that dyslipidaemia may contribute to development and progression of renal disease. For instance, hyperlipidaemia in apolipoprotein E-deficient (apoE−/−) mice is associated with glomerular inflammation, mesangial expansion and foam cell...

  • Abstracts, Hellenic Society of Nephrology.  // Kidney International;Jan1991, Vol. 39 Issue 1, p184 

    Presents several abstracts on nephrology. "Renal Pathology and Clinical Course of Silent Lupus Nephritis," by K. C. Siamopoulos, A. Drosos, F. Sotsiou, D. Psihos, M. Elisaf and H.M. Moutsopuolos; "Treatment of Lipid Abnormalities in Patients With Chronic Renal Failure," by M. Elisaf, G....

  • Kidney disease in cardiology. Charles A. Herzog // Nephrology Dialysis Transplantation;Jan2007, Vol. 22 Issue 1, p43 

    This article helps to inaugurate NDT's new section, Kidney Diseases beyond Nephrology, by focusing on the convergence of cardiology and nephrology. The clinical themes highlighted by the articles chosen for review include cardiac screening in renal transplant candidates, cardiac troponins in...

  • ESRD patient mortality with adjustment for comorbid conditions in Lombardy (Italy) versus the United States. Marcelli, Daniele; Stannard, David; Conte, Ferruccio; Held, Philip J.; Locatelli, Francesco; Port, Friedrich K. // Kidney International;Sep1996, Vol. 50 Issue 3, p1013 

    The present study evaluated end-stage renal disease (ESRD) patient survival in Lombardy, Italy, and the United States (U.S.) using data from two registries, the Lombardy Dialysis and Transplant Registry (RLDT) and the U.S. Renal Data System (USRDS), respectively. For this purpose, 4,1% white...

  • The Nephrology Nurse's Role in Improved Care of Patients with Chronic Kidney Disease. Compton, Ann; Provenzano, Robert; Johnson, Curtis A. // Nephrology Nursing Journal;Aug2002, Vol. 29 Issue 4, p331 

    Discusses how nephrology nurses can contribute to multidisciplinary clinics that work in collaboration with primary care providers to identify and manage patients with early chronic kidney disease (CKD). Estimation of kidney function; Classification of chronic kidney disease; Initiatives and...

  • Is there a common mechanism for the progression of different types of renal diseases other than proteinuria? Towards the unifying theme of chronic hypoxia. Fine, Leon G.; Bandyopadhay, Debasish; Norman, Jill T. // Kidney International Supplement;Apr2000, Issue 75, p22 

    Is there a common mechanism for the progression of different types of renal diseases other than proteinuria? Towards the unifying theme of chronic hypoxia. The question of why chronic renal diseases progress is a topic only recently investigated. Putative causes such as proteinuria do not...

  • The role of underlying nephropathy in the progression of renal disease. Locatelli, Francesco; Del Vecchio, Lucia; Andrulli, Simeone; Marai, Paolo; Tentori, Flavia // Kidney International Supplement;Apr2000, Issue 75, p49 

    The role of underlying nephropathy in the progression of renal disease. Background. Disease-specific pathogenic mechanisms may be major determinants of the spontaneous rate of progression of chronic renal failure (CRF). To clarify the role of different underlying renal diseases, we examined the...

  • In this issue.  // Kidney International;Jan2006, Vol. 69 Issue 1, p1 

    The article presents articles related to nephrology published in the January 2006 issue of "Kidney International." Inflammatory macrophages seem to play a role in diabetic nephropathy and in obstructive renal disease. Oxidative stress in end-stage renal disease is implicated in causing...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics